DNA damage response and repair

Insights into strategies for radiation sensitization of gliomas

Santosh Kesari, Sunil J. Advani, Joshua D. Lawson, Kristopher T. Kahle, Kimberly Ng, Bob Carter, Clark C. Chen

Research output: Contribution to journalReview article

20 Citations (Scopus)

Abstract

The incorporation of radiotherapy into multimodality treatment plans has led to significant improvements in glioma patient survival. However, local recurrence from glioma resistance to ionizing radiation remains a therapeutic challenge. The tumoricidal effect of radiation therapy is largely attributed to the induction of dsDNA breaks (DSBs). In the past decade, there have been tremendous strides in understanding the molecular mechanisms underlying DSB repair. The identification of gene products required for DSB repair has provided novel therapeutic targets. Recent studies revealed that many US FDA-approved cancer agents inhibit DSB repair by interacting with repair proteins. This article will aim to provide discussion of DSB repair mechanisms to provide molecular targets for radiation sensitization of gliomas and a discussion of FDA-approved cancer therapies that modulate DSB repair to highlight opportunities for combination therapy with radiotherapy for glioma therapy.

Original languageEnglish (US)
Pages (from-to)1335-1346
Number of pages12
JournalFuture Oncology
Volume7
Issue number11
DOIs
StatePublished - Nov 1 2011

Fingerprint

Glioma
DNA Repair
DNA Damage
Radiation
Radiotherapy
Therapeutics
Ionizing Radiation
Neoplasms
Recurrence
Survival
Genes
Proteins

Keywords

  • DNA damage response
  • DNA double strand break repair
  • chemotherapy
  • glioblastoma
  • radiosensitization
  • radiotherapy

Cite this

DNA damage response and repair : Insights into strategies for radiation sensitization of gliomas. / Kesari, Santosh; Advani, Sunil J.; Lawson, Joshua D.; Kahle, Kristopher T.; Ng, Kimberly; Carter, Bob; Chen, Clark C.

In: Future Oncology, Vol. 7, No. 11, 01.11.2011, p. 1335-1346.

Research output: Contribution to journalReview article

Kesari, S, Advani, SJ, Lawson, JD, Kahle, KT, Ng, K, Carter, B & Chen, CC 2011, 'DNA damage response and repair: Insights into strategies for radiation sensitization of gliomas', Future Oncology, vol. 7, no. 11, pp. 1335-1346. https://doi.org/10.2217/fon.11.111
Kesari S, Advani SJ, Lawson JD, Kahle KT, Ng K, Carter B et al. DNA damage response and repair: Insights into strategies for radiation sensitization of gliomas. Future Oncology. 2011 Nov 1;7(11):1335-1346. https://doi.org/10.2217/fon.11.111
Kesari, Santosh ; Advani, Sunil J. ; Lawson, Joshua D. ; Kahle, Kristopher T. ; Ng, Kimberly ; Carter, Bob ; Chen, Clark C. / DNA damage response and repair : Insights into strategies for radiation sensitization of gliomas. In: Future Oncology. 2011 ; Vol. 7, No. 11. pp. 1335-1346.
@article{f438727d6902498682737f7d97612420,
title = "DNA damage response and repair: Insights into strategies for radiation sensitization of gliomas",
abstract = "The incorporation of radiotherapy into multimodality treatment plans has led to significant improvements in glioma patient survival. However, local recurrence from glioma resistance to ionizing radiation remains a therapeutic challenge. The tumoricidal effect of radiation therapy is largely attributed to the induction of dsDNA breaks (DSBs). In the past decade, there have been tremendous strides in understanding the molecular mechanisms underlying DSB repair. The identification of gene products required for DSB repair has provided novel therapeutic targets. Recent studies revealed that many US FDA-approved cancer agents inhibit DSB repair by interacting with repair proteins. This article will aim to provide discussion of DSB repair mechanisms to provide molecular targets for radiation sensitization of gliomas and a discussion of FDA-approved cancer therapies that modulate DSB repair to highlight opportunities for combination therapy with radiotherapy for glioma therapy.",
keywords = "DNA damage response, DNA double strand break repair, chemotherapy, glioblastoma, radiosensitization, radiotherapy",
author = "Santosh Kesari and Advani, {Sunil J.} and Lawson, {Joshua D.} and Kahle, {Kristopher T.} and Kimberly Ng and Bob Carter and Chen, {Clark C.}",
year = "2011",
month = "11",
day = "1",
doi = "10.2217/fon.11.111",
language = "English (US)",
volume = "7",
pages = "1335--1346",
journal = "Future Oncology",
issn = "1479-6694",
publisher = "Future Medicine Ltd.",
number = "11",

}

TY - JOUR

T1 - DNA damage response and repair

T2 - Insights into strategies for radiation sensitization of gliomas

AU - Kesari, Santosh

AU - Advani, Sunil J.

AU - Lawson, Joshua D.

AU - Kahle, Kristopher T.

AU - Ng, Kimberly

AU - Carter, Bob

AU - Chen, Clark C.

PY - 2011/11/1

Y1 - 2011/11/1

N2 - The incorporation of radiotherapy into multimodality treatment plans has led to significant improvements in glioma patient survival. However, local recurrence from glioma resistance to ionizing radiation remains a therapeutic challenge. The tumoricidal effect of radiation therapy is largely attributed to the induction of dsDNA breaks (DSBs). In the past decade, there have been tremendous strides in understanding the molecular mechanisms underlying DSB repair. The identification of gene products required for DSB repair has provided novel therapeutic targets. Recent studies revealed that many US FDA-approved cancer agents inhibit DSB repair by interacting with repair proteins. This article will aim to provide discussion of DSB repair mechanisms to provide molecular targets for radiation sensitization of gliomas and a discussion of FDA-approved cancer therapies that modulate DSB repair to highlight opportunities for combination therapy with radiotherapy for glioma therapy.

AB - The incorporation of radiotherapy into multimodality treatment plans has led to significant improvements in glioma patient survival. However, local recurrence from glioma resistance to ionizing radiation remains a therapeutic challenge. The tumoricidal effect of radiation therapy is largely attributed to the induction of dsDNA breaks (DSBs). In the past decade, there have been tremendous strides in understanding the molecular mechanisms underlying DSB repair. The identification of gene products required for DSB repair has provided novel therapeutic targets. Recent studies revealed that many US FDA-approved cancer agents inhibit DSB repair by interacting with repair proteins. This article will aim to provide discussion of DSB repair mechanisms to provide molecular targets for radiation sensitization of gliomas and a discussion of FDA-approved cancer therapies that modulate DSB repair to highlight opportunities for combination therapy with radiotherapy for glioma therapy.

KW - DNA damage response

KW - DNA double strand break repair

KW - chemotherapy

KW - glioblastoma

KW - radiosensitization

KW - radiotherapy

UR - http://www.scopus.com/inward/record.url?scp=80455131269&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80455131269&partnerID=8YFLogxK

U2 - 10.2217/fon.11.111

DO - 10.2217/fon.11.111

M3 - Review article

VL - 7

SP - 1335

EP - 1346

JO - Future Oncology

JF - Future Oncology

SN - 1479-6694

IS - 11

ER -